Recep Tayyip Erdoğan University Institutional Repository
metadata only
CC BY 4.0
AXL-driven stemness and hedgehog signaling in HER2-positive breast cancer with acquired trastuzumab resistance: synergistic potential of AXL and HER2 co-targeting
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer#801333
- International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories#464248
- Real-world outcomes of CDK4/6 inhibitors in germline BRCA1/2-mutated hormone receptor-positive, HER2-negative metastatic breast cancer: Turkish oncology group (TOG) study#396732
- Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer#807224
- A Composite Assay for HER2-positive Early-stage Breast Cancer Management#880189
Record · ID 194877
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive